Many of Australia’s top brokers have been busy adjusting their financial models again, leading to the release of a large number of broker notes this week.
Three broker buy ratings that have caught my eye are summarised below. Here’s why brokers think these ASX shares are in the buy zone:
A2 Milk Company Ltd (ASX: A2M)
According to a note out of the Macquarie equities desk, its analysts have retained their outperform rating but cut the price target on this infant formula company’s shares to $17.95. The broker notes that the pandemic’s impact on the daigou channel has been much more severe than expected. While this is disappointing, the broker appears to believe it is a short term headwind and remains positive on its long term growth potential. I would agree that a2 Milk Company’s shares are a buy at the current level.
Corporate Travel Management Ltd (ASX: CTD)
Another note out of Macquarie reveals that its analysts have upgraded this corporate travel specialist’s shares to an outperform rating with an improved price target of $16.40. This follows the company’s announcement of an equity raising to fund the acquisition of Travel & Transport. Macquarie believes this is a good acquisition and notes that it will increase its scale in the lucrative United States market. I think Macquarie is spot on and Corporate Travel Management could be worth considering.
Moneyme Ltd (ASX: MME)
Analysts at Ord Minnett have retained their buy rating and $1.92 price target on this digital consumer credit company’s shares. This follows the announcement of a new $167 million warehouse funding facility. Ord Minnett notes that this has reduced its funding costs materially and expects the company to leverage this to grow its market share in new and existing verticals. I think Ord Minnett makes some good points and it could be worth a closer look.
These stocks could rocket in a Post-COVID world (FREE STOCK REPORT)
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.
Find out the names of our 3 Post COVID Stocks – For FREE!
*Returns as of 6/8/2020
More reading
- Why Corp Travel Management, EOS, Evolution, & Recce shares are charging higher
- ASX 200 down 1.1%: Corp Travel Management surges higher, gold miners rise, Santos given approval
- Why a2 Milk, BrainChip, Oil Search, & Starpharma shares are dropping lower
- Could the Bubs (ASX:BUB) share price be an A2 Milk (ASX:A2M) contender?
- Why you need to watch the Corporate Travel (ASX:CTD) share price today
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Corporate Travel Management Limited. The Motley Fool Australia owns shares of A2 Milk. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The post Top brokers name 3 ASX shares to buy today appeared first on Motley Fool Australia.
from Motley Fool Australia https://ift.tt/33ccgFr
Leave a Reply